GJB2
Gap junction beta-2 protein
Also known as: CX26, CXB2_HUMAN, DFNA3, DFNB1, NSRD1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P29033
- Gene
- GJB2
- Ensembl
- ENSG00000165474
- Chromosome
- 13
- Canonical length
- 226 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008]
Canonical amino-acid sequenceUniProt
226 residues, UniProt reviewed canonical sequence.
>P29033|GJB2
1 MDWGTLQTIL GGVNKHSTSI GKIWLTVLFI FRIMILVVAA KEVWGDEQAD FVCNTLQPGC
61 KNVCYDHYFP ISHIRLWALQ LIFVSTPALL VAMHVAYRRH EKKRKFIKGE IKSEFKDIEE
121 IKTQKVRIEG SLWWTYTSSI FFRVIFEAAF MYVFYVMYDG FSMQRLVKCN AWPCPNTVDC
181 FVSRPTEKTV FTVFMIAVSG ICILLNVTEL CYLLIRYCSG KSKKPVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GJB2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 780 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 780 nTPM
- vagina: 502 nTPM
- cervix: 419 nTPM
- salivary gland: 126 nTPM
- tonsil: 85 nTPM
- skin: 70 nTPM
Single-cell type
- esophageal apical cells: 5,412 nCPM
- esophageal suprabasal cells: 1,989 nCPM
- esophageal basal cells: 553 nCPM
- suprabasal keratinocytes: 465 nCPM
- ocular epithelial cells: 278 nCPM
- basal keratinocytes: 144 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- thalamus: 16 nTPM
- choroid plexus: 10 nTPM
- cerebellum: 3.7 nTPM
- medulla oblongata: 2.7 nTPM
- cerebral cortex: 2.5 nTPM
- midbrain: 2.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GJB2.
Disease | AllUniProt
Conditions GJB2 is implicated in, by any mechanism.
- Deafness, autosomal recessive, 1A (DFNB1A) MIM:220290
- Deafness, autosomal dominant, 3A (DFNA3A) MIM:601544
- Vohwinkel syndrome (VOWNKL) MIM:124500
- Keratoderma, palmoplantar, with deafness (PPKDFN) MIM:148350
- Keratitis-ichthyosis-deafness syndrome, autosomal dominant (KIDAD) MIM:148210
- Bart-Pumphrey syndrome (BAPS) MIM:149200
- Ichthyosis hystrix-like with deafness syndrome (HID syndrome) MIM:602540
Disease | GeneticClinVar
257 pathogenic / likely-pathogenic of 667 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal recessive nonsyndromic hearing loss 1A
- Nonsyndromic genetic hearing loss
- 7 conditions
- Rare genetic deafness
- Autosomal dominant nonsyndromic hearing loss 3A
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.98
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.72
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell-cell signaling
- gap junction assembly
- gap junction-mediated intercellular transport
- sensory perception of sound
- transmembrane transport
Molecular functions
- calcium ion binding
- gap junction channel activity
- gap junction channel activity involved in cell communication by electrical coupling
- identical protein binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GJB2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GJB2 as an antibody target. Whether an autoantibody or antibody against GJB2 could matter depends on whether native GJB2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GJB2 is annotated at the cell surface, where native GJB2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GJB2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...